system
Medical AI Inquiry: You was designed to assist in medical decision-making based on the provided user questions. It is crucial to provide accurate and comprehensive information to receive a well-informed response.  Labels: BACKGROUND, RESULTS. Meshes: ARNTL Transcription Factors, Angiotensin II, Angiotensin Receptor Antagonists, Animals, Aorta, Thoracic, Basic Helix-Loop-Helix Transcription Factors, Benzimidazoles, Biological Clocks, Biomarkers, Blotting, Northern, Cell Cycle Proteins, Cells, Cultured, Circadian Rhythm, DNA-Binding Proteins, Gene Expression, Imidazoles, Male, Mice, Mice, Inbred BALB C, Muscle, Smooth, Vascular, Nuclear Proteins, Period Circadian Proteins, Pyridines, RNA, Messenger, Rats, Receptor, Angiotensin, Type 1, Receptor, Angiotensin, Type 2, Tetrazoles, Transcription Factors.
user
Does angiotensin II induce circadian gene expression of clock genes in cultured vascular smooth muscle cells? Context: Daily rhythms of mammalian physiology and endocrinology are regulated by circadian pacemakers. The master circadian pacemaker resides in the suprachiasmatic nucleus, which is located in the hypothalamus of the brain, but circadian oscillators also exist in peripheral tissues. Because many studies have demonstrated apparent circadian variations in the frequency of cardiovascular disorders, it is of great interest to investigate a possible relation between circadian gene expression and cardiovascular function. We examined whether a circadian oscillation system exists in the aorta and/or in cultured vascular smooth muscle cells (VSMCs). The mRNA levels of clock genes were assayed by northern blot analysis. The mouse aorta showed a clear circadian oscillation in the expression of mPer2, dbp, and Bmal1. Brief treatment of VSMCs with angiotensin II induced a robust increase in mPer2 gene expression, followed by a marked reduction in mPer2 mRNA levels and subsequent synchronous cycling of mPer2, dbp, and Bmal1 mRNAs. The induction of mPer2 in VSMCs by angiotensin II was completely abolished by treatment with CV11947, a specific angiotensin II type1 receptor antagonist.
assistant
The present results demonstrate that the aorta and VSMCs possess a circadian oscillation system which is comparable to that of the suprachiasmatic nucleus and that the circadian gene expression in VSMCs is induced by angiotensin II through the angiotensin II type1 receptor. Our in vitro system will provide a useful tool to further analyze the physiological significance of the peripheral clock in cardiovascular function. Final Decision: yes